Sales of 67 drug firms grows 5.7 percent in first half: report

The combined revenue of 53 pharmaceutical companies listed in listed in Korean Stock Exchange came to 5.38 trillion won in the first half of this year, up 5.7 percent from a year earlier, a government report showed Tuesday.

According to the report by the state-run Korea Health Industry Development Institute (KHIDI), 21 firms saw their revenues rise more than 10 percent over the cited period;...